Tag Archives: AstraZeneca’s

Inquiry Begins Into AstraZeneca’s Coronavirus Vaccine Trial

Scientists on Wednesday praised the decision by AstraZeneca to suspend its late-stage coronavirus vaccine trials and begin a safety review after learning that a participant had developed a serious neurological condition. Dr. Francis Collins, the director of the National Institutes of Health, testifying at a Senate hearing on Wednesday, said the step “ought to be… Read More »